Skip to main content

RHUMBLINE ADVISERS

Position in ALKS — Alkermes plc.

CIK 1115418 BOSTON, MA

Position in ALKS

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$15,895,416
+$3,606,740 QoQ
Shares Held
449,531
+2.4% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 42.488059777857366.ToString("F0")% Shared 0.ToString("F0")% None 57.511940222142634.ToString("F0")%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ALKS
Alkermes plc.
This page
449,531 $15,895,416

All Filings in ALKS

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,895,416 449,531
2025-12-31 $12,288,676 439,195
2025-09-30 $14,215,110 473,837
2025-06-30 $13,528,438 472,857
2025-03-31 $15,030,604 455,197
2024-12-31 $13,365,174 464,714
2024-09-30 $12,960,237 463,031
2024-06-30 $11,985,243 497,313
2024-03-31 $13,253,228 489,591
2023-12-31 $13,479,920 485,938
2023-09-30 $6,670,189 238,136
2023-06-30 $7,325,389 234,038
2023-03-31 $6,463,544 229,285
2022-12-31 $5,958,606 228,037
2022-09-30 $4,830,403 216,319
2022-06-30 $5,974,771 200,563
2022-03-31 $4,541,000 172,596
2021-12-31 $3,804,777 163,576
2021-09-30 $5,108,522 165,646
2021-06-30 $3,987,883 162,638
2021-03-31 $3,059,242 163,771
2020-12-31 $3,428,926 171,876
2020-06-30 $3,289,393 169,469
2020-03-31 $2,310,372 160,220